Treatments Plot: Difference between revisions

From Glioblastoma Treatments
Jump to navigationJump to search
No edit summary
No edit summary
Line 1: Line 1:
{{#ask: [[Category:Treatments]]
{{#ask: [[Category:Treatments]]
| ?Has treatment name
| ?Has treatment name
| ?Has Usefulness Rating=Effectiveness
|?Has Usefulness Rating=Usefulness Rating
| ?Has Toxicity Level=Toxicity
|?Has Toxicity Level=toxicity_level
| ?Has Category=Category
| format=table
| format=json
| link=none
| headers=hide
| mainlabel=-
}}
}}

Revision as of 16:15, 29 May 2024

 Has treatment nameUsefulness Ratingtoxicity_level
ABT-414ABT-41424
AccutaneIsotretinoin (Accutane)33
Agenus Prophage (Heat-Shock Protein Peptide Complex-96) VaccineAgenus Prophage (Heat-Shock Protein Peptide Complex-96) Vaccine42
Angiotensin-II Receptor Blockers (ARB)Angiotensin-II Receptor Blockers (ARB)32
Angiotensin-Il Receptor Blockers (ARB)Angiotensin-Il Receptor Blockers (ARB)Not ratedNot specified
AnlotinibAnlotinib43
Anti-CMV Dendritic Cell VaccineAnti-CMV Dendritic Cell Vaccine42
BCNU (Carmustine)BCNU (Carmustine)Pending review of recent clinical trials and comparative studies4
BCNU (Carmustine) and Gliadel (Carmustine Wafers)BCNU (Carmustine) and Gliadel (Carmustine Wafers)44
Beta-blockers (especially propranolol) and the role of the sympatheticBeta-blockers (especially propranolol) and the role of the sympatheticNot ratedNot specified
Bevacizumab (Avastin)Bevacizumab (Avastin)43
CBDCBD (Cannabidiol)42
CBGCannabigerol (CBG)32
CCNU (Lomustine)CCNU (Lomustine)44
CPT-11 (Irinotecan)CPT-11 (Irinotecan)Under investigation; early results promising, especially in combination therapies3
CannabisCannabis and Cannabis-derived Products (e.g., Sativex)41
CarboplatinCarboplatinPending further clinical trials and data2
CelebrexCelebrex (Celecoxib) and Other NSAIDs32.5
ChloroquineChloroquine and Hydroxychloroquine41
Chloroquine and HydroxychloroquineChloroquine and HydroxychloroquineNot ratedNot specified
ChronotherapyChronotherapy with Temozolomide (TMZ)4Comparable to standard TMZ treatments, but timing affects management of side effects.
CurcuminCurcumin31
DNX-2401 adenovirusDNX-2401 adenovirusNot ratedNot specified
Dendritic Cell Vaccine (DCVax-L)Dendritic Cell Vaccine (DCVax-L)42
DisulfiramDisulfiram (Antabuse)32
EGFR inhibitors: Iressa, Tarceva, and Erbitux (gefitinib, erlotinib, andEGFR Inhibitors (Tarceva, Erbitux) in combination with Stupp Protocol32
Ellagic acidEllagic Acid31
Fish oilFish Oil (Omega-3 Fatty Acids: EPA and DHA)41
FotemustineFotemustineBased on available data, potentially highly useful in specific dosing schedules3
GLAGamma-Linolenic Acid (GLA)21
Gamma Knife RadiosurgeryGamma Knife Radiosurgery (GKRS) for GBM32
GarlicGarlic (Allium sativum)31
Genetically modified Poliovirus (PVS-RIPO)Genetically modified Poliovirus (PVS-RIPO)Not ratedNot specified
Gleevec (Imatinib)Gleevec (Imatinib)33
Herpes VirusHerpes VirusNot ratedNot specified
HyperthermiaHyperthermia43
ICT-107ICT-107 (Tumor-associated Antigen Vaccine)42
KeppraKeppra (Levetiracetam)42
LetrozoleLetrozole3 - Under investigation2.5
LimonenePerillyl Alcohol/Limonene32
MDNA55MDNA5532.5
MN-166MN-166 (Ibudilast)3 (awaiting research)1
MelatoninMelatonin41
Metabolic therapy with Sodium R lipoate plus hydroxycitrateSodium R Lipoate and Hydroxycitrate (METABLOC)32
MetforminMetformin32
MethadoneMethadone (D,L-methadone)32
Metronomic low dose temozolomide (TMZ)Metronomic Low-Dose Temozolomide (TMZ)43
Newcastle Disease VirusNewcastle Disease VirusNot ratedNot specified
Next-Generation CAR T-Cell Therapy for GBMNext-Generation CAR T-Cell Therapy for GBM43
OptuneOptune (Optune Gio® for newer version)52
... further results